Tagrisso 80mg Tablet
By Tagrisso
Rx
10 Tablet in a Strip

Composition
Osimertinib(80mg)

Manufacturer - AstraZeneca
Corporate & Registered Office, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, 560045, Bangalore

Expires on or after
August, 2025

liver
Tagrisso 80mg Tablet is considered safe for use in patients with liver disease. It has been determined that no specific dose adjustment of Tagrisso 80mg Tablet is necessary in these cases. This means that individuals with liver issues can typically take Tagrisso 80mg Tablet without needing to change the dosage. It is important, however, to follow the recommended dosing instructions provided by your healthcare provider to ensure the safe and effective use of Tagrisso 80mg Tablet. If you have any concerns or questions regarding the use of Tagrisso 80mg Tablet in relation to liver health, it is advisable to consult with your doctor for proper guidance.

kidney
Tagrisso 80mg Tablet is considered safe for use in patients with kidney disease. It is not necessary to adjust the dosage of Tagrisso 80mg Tablet based on kidney function.

alcohol
Consult your doctor when consuming alcohol with Tagrisso 80mg Tablet.

driving
Tagrisso 80mg Tablet typically does not impact your driving ability.

pregnancy
Tagrisso 80mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will consider risks and benefits before prescribing. Consult your doctor.

breastfeeding
Tagrisso 80mg Tablet is not recommended during breastfeeding as it may pass into breastmilk and harm the baby. It is advisable to consult a doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | M-Alkylindoles |
Therapeutic Class | - |
Action Class | Tyrosine kinase inhibitors |
₹151670
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025